tiprankstipranks
Align Technology (ALGN)
NASDAQ:ALGN
US Market
Want to see ALGN full AI Analyst Report?

Align Tech (ALGN) Stock Forecast & Price Target

3,367 Followers
See the Price Targets and Ratings of:

ALGN Analyst Ratings

Moderate Buy
12Ratings
Moderate Buy
8 Buy
3 Hold
1 Sell
Based on 12 analysts giving stock ratings to
Align
Tech
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ALGN Stock 12 Month Forecast

Average Price Target

$208.00
▲(9.43% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Align Tech in the last 3 months. The average price target is $208.00 with a high forecast of $240.00 and a low forecast of $175.00. The average price target represents a 9.43% change from the last price of $190.07.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"126":"$126","241":"$241","154.75":"$154.8","183.5":"$183.5","212.25":"$212.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":240,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$240.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":208,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$208.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":175,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$175.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[126,154.75,183.5,212.25,241],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,169.77,175.1723076923077,180.57461538461538,185.97692307692307,191.3792307692308,196.78153846153847,202.18384615384616,207.58615384615385,212.98846153846154,218.39076923076925,223.7930769230769,229.19538461538463,234.5976923076923,{"y":240,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,169.77,172.71076923076924,175.65153846153848,178.5923076923077,181.53307692307692,184.47384615384615,187.4146153846154,190.35538461538462,193.29615384615386,196.2369230769231,199.17769230769233,202.11846153846153,205.05923076923077,{"y":208,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,169.77,170.1723076923077,170.57461538461538,170.97692307692307,171.3792307692308,171.78153846153847,172.18384615384616,172.58615384615385,172.98846153846154,173.39076923076922,173.79307692307694,174.19538461538463,174.5976923076923,{"y":175,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":178.51,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":194.28,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":136.52,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":137.16,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":127.52,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":137.88,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":146.72,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156.15,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":163.63,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":189.02,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":172.73,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":178.91,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":169.77,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$240.00Average Price Target$208.00Lowest Price Target$175.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays
$200
Buy
5.22%
Upside
Reiterated
06/04/26
Analysts' Top Healthcare Picks: Kura Oncology (KURA), Align Tech (ALGN)
William Blair Analyst forecast on ALGN
William Blair
William Blair
Buy
Reiterated
06/03/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Align Tech (NASDAQ: ALGN) and AMN Healthcare Services (NYSE: AMN)
Morgan Stanley Analyst forecast on ALGN
Morgan Stanley
Morgan Stanley
$188
Hold
-1.09%
Downside
Reiterated
05/28/26
Align Technology Price Target Maintained at $188 as Erin Wright Reiterates Hold on Balanced Upside and Execution Risks
Citi
$240
Buy
26.27%
Upside
Reiterated
05/28/26
Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (NASDAQ: ASMB), Apogee Therapeutics (NASDAQ: APGE) and Align Tech (NASDAQ: ALGN)
Leerink Partners Analyst forecast on ALGN
Leerink Partners
Leerink Partners
$230
Buy
21.01%
Upside
Reiterated
05/27/26
Leerink sees numerous ways for Align to drive multi-year upsideLeerink sees numerous ways for Align to drive multi-year upside
Bank of America Securities Analyst forecast on ALGN
Bank of America Securities
Bank of America Securities
$175
Sell
-7.93%
Downside
Reiterated
05/27/26
Align Technology: Sell Rating Reiterated as Macro Headwinds Temper Near-Term Outlook; $175 Price Target Maintained
Stifel Nicolaus Analyst forecast on ALGN
Stifel Nicolaus
Stifel Nicolaus
$210
Buy
10.49%
Upside
Reiterated
05/25/26
Align Tech (ALGN) Gets a Buy from Stifel Nicolaus
Piper Sandler Analyst forecast on ALGN
Piper Sandler
Piper Sandler
$235
Buy
23.64%
Upside
Reiterated
05/15/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: RegenXBio (NASDAQ: RGNX), Align Tech (NASDAQ: ALGN) and Keros Therapeutics (NASDAQ: KROS)
Evercore ISI
$220
Buy
15.75%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH), Elanco Animal Health (NYSE: ELAN) and Align Tech (NASDAQ: ALGN)
UBS
$185$186
Hold
-2.14%
Downside
Reiterated
05/01/26
UBS Reaffirms Their Hold Rating on Align Tech (ALGN)
Mizuho Securities Analyst forecast on ALGN
Mizuho Securities
Mizuho Securities
$215$220
Buy
15.75%
Upside
Reiterated
04/30/26
Align Tech (ALGN) Gets a Buy from Mizuho Securities
Needham
$185$184
Hold
-3.19%
Downside
Reiterated
04/30/26
Align Technology Kept at Hold as Higher Gas Prices Offset Tax Refund Tailwind for Clear Aligners
HSBC
$150$200
Buy
5.22%
Upside
Upgraded
02/09/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Robert W. Baird Analyst forecast on ALGN
Robert W. Baird
Robert W. Baird
$205$218
Buy
14.69%
Upside
Reiterated
02/05/26
Align Technology price target raised to $218 from $205 at BairdAlign Technology price target raised to $218 from $205 at Baird
Wells Fargo Analyst forecast on ALGN
Wells Fargo
Wells Fargo
$181$200
Buy
5.22%
Upside
Reiterated
02/05/26
Wells Fargo Keeps Their Buy Rating on Align Tech (ALGN)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays
$200
Buy
5.22%
Upside
Reiterated
06/04/26
Analysts' Top Healthcare Picks: Kura Oncology (KURA), Align Tech (ALGN)
William Blair Analyst forecast on ALGN
William Blair
William Blair
Buy
Reiterated
06/03/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Align Tech (NASDAQ: ALGN) and AMN Healthcare Services (NYSE: AMN)
Morgan Stanley Analyst forecast on ALGN
Morgan Stanley
Morgan Stanley
$188
Hold
-1.09%
Downside
Reiterated
05/28/26
Align Technology Price Target Maintained at $188 as Erin Wright Reiterates Hold on Balanced Upside and Execution Risks
Citi
$240
Buy
26.27%
Upside
Reiterated
05/28/26
Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (NASDAQ: ASMB), Apogee Therapeutics (NASDAQ: APGE) and Align Tech (NASDAQ: ALGN)
Leerink Partners Analyst forecast on ALGN
Leerink Partners
Leerink Partners
$230
Buy
21.01%
Upside
Reiterated
05/27/26
Leerink sees numerous ways for Align to drive multi-year upsideLeerink sees numerous ways for Align to drive multi-year upside
Bank of America Securities Analyst forecast on ALGN
Bank of America Securities
Bank of America Securities
$175
Sell
-7.93%
Downside
Reiterated
05/27/26
Align Technology: Sell Rating Reiterated as Macro Headwinds Temper Near-Term Outlook; $175 Price Target Maintained
Stifel Nicolaus Analyst forecast on ALGN
Stifel Nicolaus
Stifel Nicolaus
$210
Buy
10.49%
Upside
Reiterated
05/25/26
Align Tech (ALGN) Gets a Buy from Stifel Nicolaus
Piper Sandler Analyst forecast on ALGN
Piper Sandler
Piper Sandler
$235
Buy
23.64%
Upside
Reiterated
05/15/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: RegenXBio (NASDAQ: RGNX), Align Tech (NASDAQ: ALGN) and Keros Therapeutics (NASDAQ: KROS)
Evercore ISI
$220
Buy
15.75%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH), Elanco Animal Health (NYSE: ELAN) and Align Tech (NASDAQ: ALGN)
UBS
$185$186
Hold
-2.14%
Downside
Reiterated
05/01/26
UBS Reaffirms Their Hold Rating on Align Tech (ALGN)
Mizuho Securities Analyst forecast on ALGN
Mizuho Securities
Mizuho Securities
$215$220
Buy
15.75%
Upside
Reiterated
04/30/26
Align Tech (ALGN) Gets a Buy from Mizuho Securities
Needham
$185$184
Hold
-3.19%
Downside
Reiterated
04/30/26
Align Technology Kept at Hold as Higher Gas Prices Offset Tax Refund Tailwind for Clear Aligners
HSBC
$150$200
Buy
5.22%
Upside
Upgraded
02/09/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Robert W. Baird Analyst forecast on ALGN
Robert W. Baird
Robert W. Baird
$205$218
Buy
14.69%
Upside
Reiterated
02/05/26
Align Technology price target raised to $218 from $205 at BairdAlign Technology price target raised to $218 from $205 at Baird
Wells Fargo Analyst forecast on ALGN
Wells Fargo
Wells Fargo
$181$200
Buy
5.22%
Upside
Reiterated
02/05/26
Wells Fargo Keeps Their Buy Rating on Align Tech (ALGN)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Align Tech

3 Months
Steven ValiquetteMizuho Securities
Success Rate
13/22 ratings generated profit
59%
Average Return
+10.67%
Copying Steven Valiquette's trades and holding each position for 3 Months would result in 59.09% of your transactions generating a profit, with an average return of +10.67% per trade.
1 Year
Michael RyskinBank of America Securities
Success Rate
17/22 ratings generated profit
77%
Average Return
+1.70%
Copying Michael Ryskin's trades and holding each position for 1 Year would result in 77.27% of your transactions generating a profit, with an average return of +1.70% per trade.
2 Years
Michael RyskinBank of America Securities
Success Rate
20/22 ratings generated profit
91%
Average Return
+20.68%
Copying Michael Ryskin's trades and holding each position for 2 Years would result in 90.91% of your transactions generating a profit, with an average return of +20.68% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALGN Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
19
16
21
18
18
Hold
7
6
8
5
5
Sell
2
1
2
2
2
Strong Sell
0
0
0
0
0
total
28
23
31
25
25
In the current month, ALGN has received 18 Buy Ratings, 5 Hold Ratings, and 2 Sell Ratings. ALGN average Analyst price target in the past 3 months is 208.00.
Each month's total comprises the sum of three months' worth of ratings.

ALGN Financial Forecast

ALGN Earnings Forecast

Next quarter’s earnings estimate for ALGN is $2.63 with a range of $2.51 to $2.98. The previous quarter’s EPS was $2.58. ALGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ALGN has Performed in-line its overall industry.
Next quarter’s earnings estimate for ALGN is $2.63 with a range of $2.51 to $2.98. The previous quarter’s EPS was $2.58. ALGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ALGN has Performed in-line its overall industry.

ALGN Sales Forecast

Next quarter’s sales forecast for ALGN is $1.06B with a range of $1.05B to $1.10B. The previous quarter’s sales results were $1.04B. ALGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ALGN has Performed in-line its overall industry.
Next quarter’s sales forecast for ALGN is $1.06B with a range of $1.05B to $1.10B. The previous quarter’s sales results were $1.04B. ALGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ALGN has Performed in-line its overall industry.

ALGN Stock Forecast FAQ

What is ALGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Align Technology’s 12-month average price target is 208.00.
    What is ALGN’s upside potential, based on the analysts’ average price target?
    Align Technology has 9.43% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ALGN a Buy, Sell or Hold?
          Align Technology has a consensus rating of Moderate Buy which is based on 8 buy ratings, 3 hold ratings and 1 sell ratings.
            What is Align Technology’s price target?
            The average price target for Align Technology is 208.00. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $240.00 ,the lowest forecast is $175.00. The average price target represents 9.43% Increase from the current price of $190.07.
              What do analysts say about Align Technology?
              Align Technology’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of ALGN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.